IVA

3.1408.99%
MP

Mark Pruzanski

Independent Chairman

Dr. Mark Pruzanski, M.D., is Director of Alentis Therapeutics AG from October 2025 and is its Chief Executive Officer from October 2025. Dr. Pruzanski is Chairman of Inventiva S.A. from December 2024. Dr. Pruzanski is Chairman of the Board of Verdiva Bio Limited since January 2025 and serves as its Director since October 23, 2024. He is Chairman of the Board at Abcuro, Inc. from December 2023. He founded Intercept Pharmaceuticals, Inc. in 2003. He served as Chairman and Chief Executive Officer at Versanis Bio, Inc. since July 2022. He served as Director of Egenesis Inc. from March 2021. He serves as the Member of Business Advisory Board at Excision BioTherapeutics Inc. since January 2022. Dr. Pruzanski served as Chief Executive Officer and President at Intercept Pharmaceuticals, Inc. since 2002 until January 1, 2021. He has been an Advisor of Intercept Pharmaceuticals, Inc. since January 1, 2021. Dr. Pruzanski served as the President and Chief Executive Officer at MedicinePlanet, Inc. He co-founded Kirax Corporation (Alternate Name: Tigris Pharmaceuticals, Inc.) in 2005. He served as a Venture Partner at Apple Tree Partners (ATP), which he founded in 1999, where he worked with several portfolio companies to assist them in financing, strategic positioning and operations. Prior to that, Dr. Pruzanski served at Oak Investment Partners in Connecticut as an Entrepreneur in Residence with a focus on sourcing technology and startup company origination. Dr. Pruzanski serves as a Director at Equillium, Inc. since September 2018. Dr. Pruzanski serves on the boards of the Emerging Companies Section of the Biotechnology Innovation Organization (BIO) and the Foundation for Defense of Democracies. Dr. Pruzanski has been a Director of Intercept Pharmaceuticals, Inc. since 2002. He served as a Director of Evelo Biosciences, Inc. until March 16, 2017. He served as a Director of Evelo Therapeutics, Inc. since July 12, 2016 until January 31, 2017. He served as a Director and Observer at Kirax Corporation (Alternate Name: Tigris Pharmaceuticals, Inc.). Dr. Pruzanski is a co-author of a number of scientific publications and is named as an inventor on several patents. Dr. Pruzanski is a Canadian Physician and received his M.D. from McMaster University in Ontario, an M.A. Degree in International Affairs from the Johns Hopkins School of Advanced International Studies in Bologna, Italy and Washington, DC and a Bachelor's Degree in Political Science from McGill University in Montreal, Quebec.

Positions